390 related articles for article (PubMed ID: 16645207)
21. Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma.
Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ida S; Nagai Y; Ishimoto T; Iwatsuki M; Sakamoto Y; Miyamoto Y; Baba H
Ann Surg Oncol; 2012 Aug; 19(8):2726-32. PubMed ID: 22187122
[TBL] [Abstract][Full Text] [Related]
22. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
[TBL] [Abstract][Full Text] [Related]
23. Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis.
Mikeska T; Bock C; El-Maarri O; Hübner A; Ehrentraut D; Schramm J; Felsberg J; Kahl P; Büttner R; Pietsch T; Waha A
J Mol Diagn; 2007 Jul; 9(3):368-81. PubMed ID: 17591937
[TBL] [Abstract][Full Text] [Related]
24. Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps.
Petko Z; Ghiassi M; Shuber A; Gorham J; Smalley W; Washington MK; Schultenover S; Gautam S; Markowitz SD; Grady WM
Clin Cancer Res; 2005 Feb; 11(3):1203-9. PubMed ID: 15709190
[TBL] [Abstract][Full Text] [Related]
25. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
[TBL] [Abstract][Full Text] [Related]
26. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
[TBL] [Abstract][Full Text] [Related]
27. A 115-bp MethyLight assay for detection of p16 (CDKN2A) methylation as a diagnostic biomarker in human tissues.
Zhou J; Cao J; Lu Z; Liu H; Deng D
BMC Med Genet; 2011 May; 12():67. PubMed ID: 21569495
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis.
Ota N; Kawakami K; Okuda T; Takehara A; Hiranuma C; Oyama K; Ota Y; Oda M; Watanabe G
Anticancer Res; 2006; 26(5B):3729-32. PubMed ID: 17094392
[TBL] [Abstract][Full Text] [Related]
29. Development and application of a multiplex PCR procedure for the detection of DNA methylation in colorectal cancer.
Anacleto C; Rossi B; Lopes A; Soares FA; Rocha JC; Caballero O; Camargo AA; Simpson AJ; Pena SD
Oncol Rep; 2005 Feb; 13(2):325-8. PubMed ID: 15643519
[TBL] [Abstract][Full Text] [Related]
30. Methylation of p16 and Ras association domain family protein 1a during colorectal malignant transformation.
Umetani N; de Maat MF; Sunami E; Hiramatsu S; Martinez S; Hoon DS
Mol Cancer Res; 2006 May; 4(5):303-9. PubMed ID: 16687485
[TBL] [Abstract][Full Text] [Related]
31. Quantification of epigenetic biomarkers: an evaluation of established and emerging methods for DNA methylation analysis.
Redshaw N; Huggett JF; Taylor MS; Foy CA; Devonshire AS
BMC Genomics; 2014 Dec; 15(1):1174. PubMed ID: 25539843
[TBL] [Abstract][Full Text] [Related]
32. Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients.
Baek YH; Chang E; Kim YJ; Kim BK; Sohn JH; Park DI
Dis Colon Rectum; 2009 Aug; 52(8):1452-9; discussion 1459-63. PubMed ID: 19617759
[TBL] [Abstract][Full Text] [Related]
33. Investigation of genomic methylation status using methylation-specific and bisulfite sequencing polymerase chain reaction.
Carless MA
Methods Mol Biol; 2015; 1288():193-212. PubMed ID: 25827881
[TBL] [Abstract][Full Text] [Related]
34. Promoter methylation analysis on microdissected paraffin-embedded tissues using bisulfite treatment and PCR-SSCP.
Bian YS; Yan P; Osterheld MC; Fontolliet C; Benhattar J
Biotechniques; 2001 Jan; 30(1):66-72. PubMed ID: 11196322
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight.
Weisenberger DJ; Trinh BN; Campan M; Sharma S; Long TI; Ananthnarayan S; Liang G; Esteva FJ; Hortobagyi GN; McCormick F; Jones PA; Laird PW
Nucleic Acids Res; 2008 Aug; 36(14):4689-98. PubMed ID: 18628296
[TBL] [Abstract][Full Text] [Related]
36. Colorimetric silver detection of methylation using DNA microarray coupled with linker-PCR.
Ji M; Hou P; Li S; He N; Lu Z
Clin Chim Acta; 2004 Apr; 342(1-2):145-53. PubMed ID: 15026275
[TBL] [Abstract][Full Text] [Related]
37. Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation with better prognosis in colorectal cancer patients with microsatellite instability tumors.
Veganzones S; Maestro ML; Rafael S; de la Orden V; Vidaurreta M; Mediero B; Espantaleón M; Cerdán J; Díaz-Rubio E
Tumour Biol; 2015 May; 36(5):3853-61. PubMed ID: 25576161
[TBL] [Abstract][Full Text] [Related]
38. Investigation of genomic methylation status using methylation-specific and bisulfite sequencing polymerase chain reaction.
Carless M
Methods Mol Biol; 2009; 523():217-34. PubMed ID: 19381936
[TBL] [Abstract][Full Text] [Related]
39. Densely methylated MLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancers.
Furukawa T; Konishi F; Masubuchi S; Shitoh K; Nagai H; Tsukamoto T
Genes Chromosomes Cancer; 2002 Sep; 35(1):1-10. PubMed ID: 12203784
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of DNA methylation in the promoter region of the methylguanine-O(6) -DNA-methyltransferase gene by COBRA and subsequent native capillary gel electrophoresis.
Goedecke S; Mühlisch J; Hempel G; Frühwald MC; Wünsch B
Electrophoresis; 2015 Dec; 36(23):2939-50. PubMed ID: 26331436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
